Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non–Small Cell Lung Cancer
This case series assesses overall and progression-free survival and safety outcomes of chemotherapy and immunotherapy combination treatment in patients 75 years and older with non–small cell lung cancer.